Europe rejects approval for Alzheimer's from lecanemab, a drug that slows down cognitive decline

Press/Media: Research

Period26 Jul 2024

Media contributions

1

Media contributions

  • TitleEurope rejects approval for Alzheimer's from lecanemab, a drug that slows down cognitive decline
    Media name/outletEl Mundo
    Media typeWeb
    Country/TerritorySpain
    Date26/07/24
    PersonsTara Spires-Jones